Terms: = Prostate cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Diagnosis
10 results:
1. Molecular imaging and treatment of PSMA-positive prostate cancer with
Jiao Y; Xu P; Luan S; Wang X; Gao Y; Zhao C; Fu P
Nucl Med Biol; 2022; 104-105():28-37. PubMed ID: 34847481
[TBL] [Abstract] [Full Text] [Related]
2. Nucleic acids therapeutics using PolyPurine Reverse Hoogsteen hairpins.
Noé V; Aubets E; Félix AJ; Ciudad CJ
Biochem Pharmacol; 2021 Jul; 189():114371. PubMed ID: 33338475
[TBL] [Abstract] [Full Text] [Related]
3. Stromal osseous metaplasia in urothelial carcinoma of the bladder: a rare case report and literature review.
Razafimahefa J; Gosset C; Mongiat-Artus P; Andriamampionona TF; Verine J
Diagn Pathol; 2019 Jul; 14(1):75. PubMed ID: 31299983
[TBL] [Abstract] [Full Text] [Related]
4. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
5. SNP285C modulates oestrogen receptor/Sp1 binding to the mdm2 promoter and reduces the risk of endometrial but not prostatic cancer.
Knappskog S; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; ; Romundstad P; Hveem K; Vatten L; Salvesen HB; Lønning PE
Eur J Cancer; 2012 Sep; 48(13):1988-96. PubMed ID: 22119201
[TBL] [Abstract] [Full Text] [Related]
6. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.
Sun T; Lee GS; Oh WK; Pomerantz M; Yang M; Xie W; Freedman ML; Kantoff PW
Clin Cancer Res; 2010 Nov; 16(21):5244-51. PubMed ID: 20855462
[TBL] [Abstract] [Full Text] [Related]
7. Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?
Mandal RK; Mittal RD
Urol Oncol; 2012 Sep; 30(5):555-61. PubMed ID: 20822933
[TBL] [Abstract] [Full Text] [Related]
8. No evidence for association of the mdm2-309 T/G promoter polymorphism with prostate cancer outcomes.
Jaboin JJ; Hwang M; Perez CA; Cooper C; Chen H; Ye C; Cai Q; Wills ML; Lu B
Urol Oncol; 2011; 29(3):319-23. PubMed ID: 19523862
[TBL] [Abstract] [Full Text] [Related]
9. Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
Kibel AS; Jin CH; Klim A; Luly J; A Roehl K; Wu WS; Suarez BK
Prostate; 2008 Aug; 68(11):1179-86. PubMed ID: 18459109
[TBL] [Abstract] [Full Text] [Related]
10. Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.
Lehmann BD; McCubrey JA; Terrian DM
Cancer Biol Ther; 2007 Aug; 6(8):1165-70. PubMed ID: 18059157
[TBL] [Abstract] [Full Text] [Related]
